Creatine for Sarcopenia, Muscle Strength and Bone Density: The 2024 Meta-Analysis of 1,093 Adults

Sarcopenia — the progressive, age-related loss of skeletal muscle mass and strength — is one of the most clinically significant and under-recognised drivers of morbidity and mortality in ageing populations. It is not merely a cosmetic concern. Skeletal muscle is the body's primary glucose disposal tissue, its largest amino acid reservoir, a major determinant of metabolic rate, and the physical foundation of functional independence. Loss of muscle mass directly drives insulin resistance, metabolic syndrome, falls, fractures, functional disability, and reduced quality of life.

The clinical evidence base for creatine monohydrate in sarcopenia prevention and treatment — particularly when combined with resistance training — is more substantial and more recent than most people realise.

The 2024 Meta-Analysis: 20 RCTs, 1,093 Adults Over 55

A systematic review and meta-analysis (published in PMC, literature search extended to August 2024) synthesised 20 RCTs examining creatine supplementation combined with exercise training in adults aged 55 and above, totalling 1,093 participants (69% female, 31% male). This is the most comprehensive and up-to-date quantitative synthesis of creatine's effects in older adults to date.

Key findings:

• Muscle strength (1RM): Significant improvement in 1-repetition maximum strength compared to exercise plus placebo (mean difference = 2.122 kg, p = 0.001) — confirming creatine adds meaningful strength beyond what exercise alone achieves
• Lean body mass: Significant increases in whole-body lean body mass in the creatine plus exercise group vs exercise alone
• Bone mineral density: Significant improvements in bone area and thickness, particularly relevant for postmenopausal women at highest risk of osteoporosis
• Functional ability: Improvements in functional performance measures relevant to daily living and fall prevention

The consistency of these findings across 20 independent trials, and the large combined sample size of over 1,000 predominantly older female participants, provides strong evidence for creatine's clinical relevance in this population.

Why Creatine + Resistance Training Is the Gold Standard

An important nuance confirmed across multiple reviews: creatine alone, without exercise, produces modest effects on muscle strength and physical performance in older adults. The most substantial and consistent benefits occur when creatine is combined with resistance training. This is mechanistically coherent:

• Resistance training stimulates muscle protein synthesis (MPS) and signals muscle hypertrophy through the mTOR pathway
• Creatine supplementation increases intramuscular phosphocreatine stores, enabling harder training sessions (more volume, more power output) before fatigue limits performance
• The combination produces superadditive effects — the training stimulus is larger because creatine-enhanced energy availability allows greater mechanical loading, and the recovery environment is more anabolic
• At the molecular level, a 12-week rat study comparing exercise alone, creatine alone, CoQ10 alone, and the combination of exercise + creatine found the combination produced substantially greater improvements in serum lipid profiles, antioxidant indicators, and sarcopenic index markers than any single intervention

The practical implication: for adults over 40, any resistance training programme should include creatine monohydrate supplementation — and anyone taking creatine should be doing some form of resistance training to maximise the benefit.

The Bone Density Mechanism

Bone density benefits from creatine are less well-known than its muscle effects but are increasingly well-supported. The mechanism involves the creatine kinase energy system in osteoblasts — the bone-forming cells responsible for building and remodelling bone tissue. Osteoblasts have high ATP demands during bone formation, and the phosphocreatine buffer supports the energy-intensive process of mineralisation and collagen matrix synthesis.

Multiple RCTs in postmenopausal women — the population at highest clinical risk for osteoporosis — have found creatine combined with resistance training produces significantly greater bone mineral density (BMD) improvements at the hip and spine compared to resistance training plus placebo. The July 2025 JISSN narrative review (Candow et al.) explicitly identified creatine's application for osteoporosis treatment and prevention alongside its well-established sarcopenia indications.

For women approaching or past menopause — when the rapid decline in oestrogen directly accelerates both muscle and bone loss — creatine monohydrate combined with resistance training represents one of the most evidence-backed and accessible non-pharmacological interventions available.

Functional Independence and Fall Prevention

The downstream consequence of sarcopenia that matters most for quality of life is loss of functional independence — the ability to perform activities of daily living, maintain balance and mobility, and avoid falls. Falls in older adults are the leading cause of injury-related hospitalisation and a major trigger for long-term care dependency.

Creatine's effects on functional performance extend beyond pure muscle strength measures. Improvements in lower body power (the ability to generate force rapidly — critical for fall recovery and balance correction), grip strength, and walking speed have all been documented in RCTs in older adults. These functional outcomes are the downstream clinical consequence of preserving the muscle mass and quality that creatine supports.

Metabolic Health: Glucose and Insulin Sensitivity

Beyond muscle and bone, creatine supplementation shows benefits for glucose metabolism — a major driver of accelerated ageing. The 2025 JISSN review confirmed beneficial effects on glucose kinetics in older adults. The mechanisms are primarily indirect:

• Greater skeletal muscle mass increases the total capacity for glucose disposal (muscle is responsible for approximately 80% of insulin-stimulated glucose uptake)
• Creatine may also directly improve GLUT4 transporter expression and activity, enhancing insulin-stimulated glucose transport independent of muscle mass changes
• Reduced visceral fat (a consequence of the improved body composition from creatine + resistance training) further improves insulin signalling

For adults with pre-diabetes, metabolic syndrome, or simply the insulin resistance that accumulates with age, creatine's combined effects on muscle mass and glucose metabolism make it particularly relevant.

Homocysteine Reduction: The Cardiovascular Angle

Creatine synthesis from methionine consumes S-adenosylmethionine (SAM) — the universal methyl donor. When creatine synthesis is supplemented from dietary sources, less SAM is consumed for endogenous synthesis, leaving more available for homocysteine remethylation back to methionine. The net effect is reduced plasma homocysteine — an independent cardiovascular risk factor elevated in 30–40% of adults over 50. This homocysteine-lowering effect of creatine supplementation has been confirmed in several clinical studies and represents a meaningful cardiovascular benefit that adds to creatine's anti-ageing profile.

Practical Protocol for Anti-Ageing Applications

• Dose: 3–5g creatine monohydrate daily — the ISSN-recommended maintenance dose that achieves and maintains full muscle saturation
• With resistance training: 2–3 sessions per week of progressive resistance training maximises the creatine benefit for both muscle and bone outcomes
• Consistency over timing: Daily consistency matters more than exact timing; the muscle creatine pool refills gradually and benefits accumulate over weeks
• For postmenopausal women specifically: 3–5g/day with a progressive resistance training programme targeting the hip and spine is the most evidence-backed combination for bone density preservation